[Pharmacological properties of a series of niflumic acid derivatives].
D000814:Aniline Compounds / Q000494:pharmacology; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology*; D002199:Capillary Permeability / Q000187:drug effects; D005461:Fluorine / Q000494:pharmacology; D006099:Granuloma / Q000517:prevention & control; D007249:Inflammation / Q000188:drug therapy; D007928:Lethal Dose 50; D051379:Mice; D009420:Nervous System / Q000187:drug effects; D009539:Nicotinic Acids / Q000494:pharmacology*; D011725:Pyridines / Q000494:pharmacology / Q000633:toxicity*; D051381:Rats; D013329:Structure-Activity Relationship
D000814:Aniline Compounds; D000893:Anti-Inflammatory Agents; D009539:Nicotinic Acids; D011725:Pyridines; D005461:Fluorine
Proprietà farmacologiche di una serie di derivati dell'acido niflumico.